Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Earlier treatment in prostate cancer: How can we maximize the therapeutic index? 

Quality of life (QoL) and long-term comorbidities  

Date

16 Sep 2021

Session

Earlier treatment in prostate cancer: How can we maximize the therapeutic index? 

Topics

Management of Systemic Therapy Toxicities;  Supportive Care and Symptom Management

Tumour Site

Prostate Cancer

Presenters

Heather Payne

Authors

H.A. Payne

Author affiliations

  • Oncology, UCLH - University College London Hospitals NHS Foundation Trust, NW1 2PG - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Silke Gillessen

Session: Earlier treatment in prostate cancer: How can we maximize the therapeutic index? 

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.